Aspen Pharmacare Holdings Limited (APNHF) Comparison with companies in other sectors?

Aspen Pharmacare Holdings Limited has a share price of 444.23M. You can analyze Aspen Pharmacare Holdings Limited (APNHF) competitors across different market sectors through stock heatmaps.

What are APNHF's NET and operating margins?

Aspen Pharmacare Holdings Limited (APNHF) operating margin is around 0.17, and net profit margin is approximately 0.08 as of the latest reports.

In what way does APNHF's earnings per share (EPS) trend reflect its financial momentum?

Aspen Pharmacare Holdings Limited (APNHF) EPS is 0.57 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Aspen Pharmacare Holdings Limited is 12.72, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Aspen Pharmacare Holdings Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Aspen Pharmacare Holdings Limited like P/E which is 17.11, P/B which is 0.67, and PEG which is -0.03. Compare them with sector averages to evaluate if the stock is priced fairly.

Aspen Pharmacare Holdings Limited

APNHF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$7.25

$0.00(0.00%)

Aspen Pharmacare Holdings Limited (APNHF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.57

P/E Ratio

12.72

ROE

0.04%

Net Margin

0.08%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.22B

Shares OutstandingTotal number of shares issued

$444.23M

Book Value/ShareNet worth per share

$191.07

Revenue/ShareAnnual revenue per share

$100.29

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.57

Net MarginNet income as percentage of revenue

7.50%

Operating MarginOperating income as percentage of revenue

17.46%

ROEReturn on shareholders' equity

3.92%

ROAReturn on total assets

2.40%

ROCEReturn on capital employed

6.78%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$3.87

Cash/ShareCash and equivalents per share

$27.78

FCF YieldFree cash flow as percentage of market cap

3.007%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$3.67

Dividend YieldAnnual dividend as percentage of stock price

2.85%

Financial Ratios Analysis data is not available for APNHFFinancial Ratios Analysis details for APNHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for APNHFSector Benchmarking details for APNHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Aspen Pharmacare Holdings Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Aspen Pharmacare Holdings Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Aspen Pharmacare Holdings Limited's unique business strengths and challenges.

Key Financial Metrics for Aspen Pharmacare Holdings Limited

For Aspen Pharmacare Holdings Limited, essential financial indicators include EPS 0.57, PE 12.72, and ROE 0.04. These key ratios reveal insights into Aspen Pharmacare Holdings Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Aspen Pharmacare Holdings Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Aspen Pharmacare Holdings Limited

Metrics like Net Margin 7.50% and ROA 2.40% shed light on how well Aspen Pharmacare Holdings Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Aspen Pharmacare Holdings Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Aspen Pharmacare Holdings Limited

Using ratios such as P/B Ratio 0.67 and PEG Ratio -0.03, investors can assess whether Aspen Pharmacare Holdings Limited is appropriately valued based on its financials and growth potential. These figures, combined with Aspen Pharmacare Holdings Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Aspen Pharmacare Holdings Limited

Financial health indicators, such as Debt/Equity Ratio 0.43 and Cash Flow $3.87, provide a snapshot of Aspen Pharmacare Holdings Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Aspen Pharmacare Holdings Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Aspen Pharmacare Holdings Limited

Investing in Aspen Pharmacare Holdings Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Aspen Pharmacare Holdings Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;